References
- BartoloniABartalesiFMantellaAHigh prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumptionJ Infect Dis200418971291129415031799
- RahalJJUrbanCSegal-MaurerSNosocomial antibiotic resistance in multiple Gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sitesClin Infect Dis200234449950311797177
- LautenbachEAntimicrobial resistance in Gram-negative pathogens: crafting the tools necessary to navigate the long ascent out of the abyssJ Infect Dis2009200683884019673645
- van de Sande-BruinsmaNGrundmannHVerlooDAntimicrobial drug use and resistance in EuropeEmerg Infect Dis200814111722173018976555
- DrummondCWResistance is futile – a conference to promote the rational use of antimicrobials in acute hospitalsJ Antimicrob Chemother200657217117516319179
- NtagiopoulosPGParamythiotouEAntoniadouAGiamarellouHKarabinisAImpact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an intensive care unit in GreeceInt J Antimicrob Agents200730436036517629680
- de AraujoORda SilvaDCDieguesARCefepime restriction improves Gram-negative overall resistance patterns in neonatal intensive care unitBraz J Infect Dis200711227728017625777
- BurkeJPAntibiotic resistance – squeezing the balloon?JAMA199828014127012719786379
- LivermoreDHas the era of untreatable infections arrived?J Antimicrob Chemother200964Suppl 1i29i3619675016
- HoranTCGaynesRPSurveillance of nosocomial infectionsMayhallCGHospital Epidemiology and Infection Control3rd edPhiladelphia, PALippincott Williams and Wilkins200416591702
- Clinical and Laboratory Standards InstituteAnalysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data: Approved Guideline3rd ed CLSI document M39-A3.Wayne, PAClinical and Laboratory Standards Institute2009
- KirkwoodBRSterneJAEssential Medical Statistics2nd edMalden, MABlackwell Science2003502
- LimaALOliveiraPRPaulaAPZumiottiAVInfluence of ertapenem administration on the incidence of carbapenem-resistant Pseudomonas aeruginosaBraz J Infect Dis200812210510618641844
- LimaALOliveiraPRPaulaAPDal-PazKRossiFZumiottiAVThe impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case studyInfect Control Hosp Epidemiol200930548749019335227
- LimaALOliveiraPRPaulaAPCarbapenem stewardship: positive impact on hospital ecologyBraz J Infect Dis20111511521412581
- DuBChenDLiuDRestriction of third-generation cephalosporin use decreases infection-related mortalityCrit Care Med20033141088109312682477
- BrahmiNBlelYKouraichiNImpact of ceftazidime restriction on Gram-negative bacterial resistance in an intensive care unitJ Infect Chemother200612419019416944257
- MeyerELapatschekMBechtoldASchwarzkopfGGastmeierPSchwabFImpact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICUIntensive Care Med200935586287019034426
- RahalJJUrbanCHornDClass restriction of cephalosporin use to control total cephalosporin resistance in nosocomial KlebsiellaJAMA199828014123312379786372
- CantónRCoboJHospital antibiotic use and resistance: a relationship that is difficult to measure and complex to interpretEnferm Infecc Microbiol Clin2009278437440 [Spanish.]19646792
- BissonGFishmanNOPatelJBEdelsteinPHLautenbachEExtended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalenceInfect Control Hosp Epidemiol200223525426012026150